Skip to main content
Log in

Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Administration of drugs that reduce the influence of dopamine at its receptor site can lead to postsynaptic supersensitivity, whereas treatment with dopamine (DA) agonists can cause postsynaptic subsensitivity. Both unaltered and enhanced postsynaptic responses to DA have been shown after pretreatment with DA agonists. In the present manuscript pretreatment with apomorphine, a dopaminergic agonist, is shown to induce either increased or reduced locomotor activity. When a drug-free period between successive injections was allowed, apomorphine induced an enhanced locomotor response, whereas a reduced response occurred when each dose was injected before the previous apomorphine dose had been completely metabolized. Pretreatment with both high (1 and 3 mg/kg) and low (0.05 mg/kg) apomorphine doses enhanced the response. Apomorphine treatment that caused enhanced locomotor responses did not modify the stereotypy response to the drug. Similar enhanced or reduced response were found in rats with partial lesions of the nigrostriatal system. These altered responses to DA agonists may have important clinical consequences. The present data also suggest the existence of a different DA systems for locomotor and stereotypy actions of dopaminergic agonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bailey RC, Jackson DM (1978) A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration. Psychopharmacology 56:317–326

    Google Scholar 

  • Bailey RC, Jackson DM, Bracs PV (1979) Long-term l-dopa pretreatment of mice: central receptor subsensitivity or supersensitivity. Psychopharmacology 66:55–61

    Google Scholar 

  • Baldessarini RJ, Tarsy D (1979) Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. Int Rev Neurobiol 21:1–45

    Google Scholar 

  • Bitran M, Bustos G (1982) On the mechanism of presynaptic autoreceptor-mediated inhibition of transmitter synthesis in dopaminergic nerve terminals. Biochem Pharmacol 31:2851–2860

    Google Scholar 

  • Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326–328

    Google Scholar 

  • Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144

    Google Scholar 

  • Cooper JR, Bloom FE, Roth RH (1982) The biochemical basic of neuropharmacology. Oxford University Press, 4th edition, New York, pp 173–223

    Google Scholar 

  • Costall B, Fortune DH, Naylor R, Nohria V (1979) A study of drug action on normal and denervated striatal mechanisms. Eur J Pharmacol 56:207–216

    Google Scholar 

  • Costentin J, Protais P, Schwartz JC (1975) Rapid and dissociated changes in the sensitivities of different dopamine receptors in mouse brain. Nature 257:405–407

    Google Scholar 

  • De Mello MCF, Ventura ALM, De Carbalho RP, Klein WL, De Mello FG (1982) Regulation of dopamine and adenosine-dependent adenylate cyclase systems of chicken embryo retina cells in culture. Proc Natl Acad Sci USA 79:5708–5712

    Google Scholar 

  • Direngeld LK, Feldman RG, Alexander MP, Kelly-Hayses M (1980) Is l-dopa drug holiday useful? Neurology 30:785–788

    Google Scholar 

  • Goetz CG, Tanner CM, Nauseda PA (1981) Weekly drug holiday in parkinson disease. Neurology 31:1460–1462

    Google Scholar 

  • Hanbauer I, Gimble J, Lovenbert W (1979) Changes in soluble calmodulin following activation of dopamine receptors in rat striatal slices. Neuropharmacology 18:851–857

    Google Scholar 

  • Hefti F, Melamed E, Wurtman RJ (1980) Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res 195:123–137

    Google Scholar 

  • Jenkins O, Bailey R, Crisp E, Jackson DM (1980) Subacute l-dopa in mice: Biochemical and behavioural effects. Psychopharmacology 68:77–83

    Google Scholar 

  • Klawans HL Jr (1973) The pharmacology of tardive dyskinesias. Am J Psychiatry 130:82–86

    Google Scholar 

  • Koller WC (1982) Alternate day levodopa therapy in parkinsonism. Neurology 32:324–326

    Google Scholar 

  • Kurlan R, Shoulson I (1982) Up and down regulation: clinical significanse of nervous system receptor-drug interactions. Clin Neuropharmacol 5:345–350

    Google Scholar 

  • Ljungberg T, Ungerstedt U (1977) Different behavioural patterns induced by apomorphine evidence that the method of administration determines the behavioural response to the drug. Eur J Pharmacol 46:45–50

    Google Scholar 

  • Ljungberg T, Ungerstedt U (1978) Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action. Psychopharmacology 56:239–247

    Google Scholar 

  • Lydin HP, Bass-Verry F (1976) Study of deterioration in long-term treatment of parkinsonism with l-dopa plus decarboxylase inhibitor. J Neural Transm 38:249–258

    Google Scholar 

  • Magnusson O, Nilsson LB, Westerlund D (1980) Simultaneous determination of dopamine, dopac and homovanillic acid. J Chromatogr 221:237–247

    Google Scholar 

  • Marsden CD, Parkes JC (1977) Success and problems of long-term levodopa therapy in parkinson's disease. Lancet 1:345–349

    Google Scholar 

  • Memo M, Pradhan S, Hanbauer I (1981) Cocaine-induced supersensitivity of striatal dopamine receptors: role of endogenous calmodulin. Neuropharmacology 20:1145–1150

    Google Scholar 

  • Memo M, Lovenberg W, Hanbauer I (1982) Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum. Proc Natl Acad Sci USA 79:4456–4460

    Google Scholar 

  • Montanaro N, Dall'olio R, Gandolfi O, Vaccheri A (1982) Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol. Eur J Pharmacol 81:1–9

    Google Scholar 

  • Moore KE, Thornburg JE (1975) Drug-induced dopaminergic supersensitivity. Adv Neurol 9:93–104

    Google Scholar 

  • Muller P, Seeman P (1978) Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology 60:1–11

    Google Scholar 

  • Nausieda PA, Weiner WJ, Kanapa DJ, Klawans HL (1978) Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism. Neurology 28:1183–1188

    Google Scholar 

  • Nelson LR, Ellison G (1978) Enhanced stereotipies after repeated injections but not continuous amphetamines. Neuropharmacology 17:1081–1084

    Google Scholar 

  • Nowycki MC, Roth RH (1978) Dopaminergic neurons: role of presynaptic receptors in the regulation of transmitter biosynthesis. Prog Neuro-Psychopharmacol 2:139–158

    Google Scholar 

  • Post RM, Kopanda RT, Black KE (1976) Progressive effects of cocaine on behavior and central amine metabolism in rhesus monkeys: relationship to kindling and psychosis. Biol Psychiatry 11:403–408

    Google Scholar 

  • Post RM, Rose H (1976) Increasing effects of repetitive cocaine administration in the rat. Nature 260:731–732

    Google Scholar 

  • Rinne UK, Koskinen V, Lonnberg P (1980) Neurotransmitter receptors in the parkinsonian brain. In: Rinne UK, Klinger M, Stamm G (eds) Parkinson's disease-current progress problems and management. Amsterdam; Elsevier, pp 93–107

    Google Scholar 

  • Rinne UK, Lonnberg P, Koskinen V (1981) Dopamine receptors in the parkinsonian brain. J Neural Transm 51:97–109

    Google Scholar 

  • Robinson TE, Becker JB, Presty SK (1982) Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res 253:231–241

    Google Scholar 

  • Sahakian BJ, Robbins TW, Iversen SD (1976) Alpha-flupenthixol-induced hyperactivity by chronic dosing in rats. Eur J Pharmacol 37:169–178

    Google Scholar 

  • Seeger TF, Thal L, Gardner EL (1982) Behavioral and Biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology 76:182–187

    Google Scholar 

  • Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32:229–313

    Google Scholar 

  • Segal DS, Weinberger SB, Cahill J, McCunney SJ (1980) Multiple daily amphetamine administration: behavioral and neurochemical alterations. Science 207:904–907

    Google Scholar 

  • Smith RV, Wilcox RE, Soine WH, Riffee WH, Baldessarini RJ, Kula NS (1979) Plasma levels of apomorphine following intravenous intraperitoneal and oral administration to mice and rats. Res. Commun Chem Pathol Pharmacol 24:483–499

    Google Scholar 

  • Smith RV, Wilcox RE, Velagapudi RB (1983) Covalent binding of a dopamine agonist, apomorphine, in striatum after chronic administration. Soc Neurosci Abstr 9:1111

    Google Scholar 

  • Swett RD, Lee JE, Spiegel HE, Dowell F (1972) Enhanced response to low doses of levodopa after withdrawal from chronic treatment. Neurology 22:520–525

    Google Scholar 

  • Trulson ME, Crisp T (1982) Behavioral and neurochemical effects of apomorphine in the cat. Eur J Pharmacol 80:295–309

    Google Scholar 

  • Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69–93

    Google Scholar 

  • Von Voigtlander PF, Losey EG, Triezenberg HJ (1975) Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. J Pharmacol Exp Ther 193:88–94

    Google Scholar 

  • Watanabe H, Nakand S, Ogawa N (1982) Age difference in apomorphine induced stereotypy in rats: relationship to plasma and brain concentrations. Psychopharmacology 76:57–61

    Google Scholar 

  • Weiner WJ, Goetz CG, Nausieda PA, Klawans HL (1979) Amphetamine induced hypersensitivity in guinea pigs. Neurology 29:1054–1057

    Google Scholar 

  • Weiner WJ, Koller WC, Perlik S, Nausieda PA, Klawans HL (1980) Drug holiday and management of parkinson's disease. Neurology 30:1257–1261

    Google Scholar 

  • White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054–1057

    Google Scholar 

  • Wilcox RE, Riffee WH, H-Chun Chen P, Kammetlt III S, Smith RV (1980) Behavioral facilitation following chronic administration of N-n-propylnorapomorphine. Psychopharmacology 72:113–115

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castro, R., Abreu, P., Calzadilla, C.H. et al. Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval. Psychopharmacology 85, 333–339 (1985). https://doi.org/10.1007/BF00428198

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00428198

Key words

Navigation